Search research articles

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Detection of <sub>OXA-23</sub> Among Carbapenem-Resistant Acinetobacter baumannii Isolated From Intensive Care Units of a Tertiary Care Hospital in Pakistan.

MicrobiologyOpen·2026

Same author

A Tissue-Homologous Keratin-PBA Hydrogel Integrating Rationally Designed Nanomicelles Enables Microenvironment-Adaptive Repair of Chronic Diabetic Wounds.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Myopericarditis Secondary to Toxoplasma Gondii Infection in an Immunocompetent Young Male-A Case Report.

Reports (MDPI)·2026

Same author

Trapped Fourth Ventricle in a Pediatric Patient With a History of Post-Traumatic Hydrocephalus and Ventriculoperitoneal Shunt: A Case Report and Literature Review.

Clinical case reports·2026

Same author

Longitudinal Trends and Outcomes in Transcatheter Aortic Valve Implantation: a report from the SwissTAVI Registry.

Cardiovascular intervention and therapeutics·2026

Same author

Histiocytic Sarcoma of Palatine Tonsil in a Pediatric Patient: A Case Report of a Rare and Aggressive Malignancy.

Clinical case reports·2026

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Updated: Jul 1, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

脏缩需要心血管结果驱动的数据吗?

Syedah Aleena Haider^1,2, Max Wagener³, Talha Iqbal⁴

¹Department of Cardiology, University Hospital Galway, Galway, Ireland. ahaider93@hotmail.com.

Hypertension research : official journal of the Japanese Society of Hypertension

|March 11, 2024

概括

与假冒手术相比,损伤 (RDN) 有效地降低了血压. 分析试验数据表明,降低血压是心血管结果的足够替代品,简化了高血压治疗研究.

关键词:

抗高血压剂抗高血压剂在高血压的高血压.交感切除术是指一个共感切除术.治疗结果的结果.

更多相关视频

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Published on: February 14, 2018

相关实验视频

Last Updated: Jul 1, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Published on: February 14, 2018

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
腎臟病學 (nephrology) 是一種醫學.

背景情况:

高血压是一个全球性的健康挑战,导致严重的心血管疾病.
脏缺血 (RDN) 已成为控制血压 (BP) 的潜在治疗方法.
最近的试验评估了RDN的有效性和安全性,对结果措施的讨论是混合的.

研究的目的:

分析 RDN 试验中关于终点定义的统计方法.
为了确定主要不良心血管事件 (MACE) 驱动试验与血压降低作为替代终点的必要性.
提供证据支持使用降血压作为RDN研究中心血管结果的有效替代品.

主要方法:

系统性审查和分析主要假控随机对照试验RDN中使用的统计方法.
对终点定义的评估,重点是将BP降低和MACE作为试验结果之间的比较.
对支持降低血压作为心血管结果的替代品的证据的统计评估.

主要成果:

大多数模拟控制的RDN试验表明,与对照组相比,24小时/天的门诊性缩血压显著降低.
对统计方法的分析支持了RDN显著降低血压的结论,而不是假的对照.
用血压降低作为替代终点的使用得到了试验数据和MACE驱动试验的实际限制的支持.

结论:

RDN是一种经过验证的方法,可显著降低高血压患者的血压.
降低血压在RDN试验中充当了足够的替代终点,简化了结果评估.
将BP视为替代终点为未来高血压研究和治疗策略提供了优势,特别是考虑到长期MACE评估的挑战.